Fabric imbued with optical fibers helps fight skin diseases

February 23, 2018 by Bob Yirka, Medical Xpress report
Credit: PHOS-ISTOS-project

A team of researchers with Texinov Medical Textiles in France has announced that their PHOS-ISTOS system, called the Fluxmedicare, is on track to be made commercially available later this year. The system consists of a piece of fabric imbued with optical fibers and a control mechanism. The system is meant to be used for treatment of skin diseases such as acne, psoriasis and actinic keratosis.

The goal of the project was to create a flexible light-emitting textile for use in (PDT) of actinic keratoses—a skin disease characterized by rough patches. The program was initiated in response to requests by people in the medical community looking to replace traditional PDT systems—systems currently in use involve large light panels directed at patients which in addition to treating skin, cause redness and .

The new system works fundamentally the same as current systems—a cream is applied to the skin followed by treatment with light. The light speeds up a reaction between a photosensitizer in the cream and oxygen in the air. The difference is in the light source. Instead of a large panel, optical fibers knitted into a fabric emit enough light to speed up the reaction, but do so without causing pain. After the cream is applied to the skin, the fabric is placed directly on the body over the impacted area.

Fluxmedicare has been undergoing clinical trials at University Hospital, Lille France and at Klinikum Vest in Germany. Dr. Nadege Boucard, a spokesperson for the team working on the project has described it as an unprecedented system for treating skin conditions. He noted also that in addition to effectively treating a wide variety of skin ailments, the new system actually works better because of its wraparound nature. Light is emitted evenly to every part of the body, which, he pointed out, means the beams are homogeneous. A report from the clinical trial team gave an average ranking of pain for the new system of 0 to 1, which Boucard describes as a 90 percent drop. He has further noted that the cost of the system will be approximately €5,000, just a third of those now in use.

Explore further: Vitiligo treated successfully with arthritis drug and light therapy

Related Stories

Vitiligo treated successfully with arthritis drug and light therapy

January 31, 2018
Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy—the medication and light—to restore skin ...

Researchers discover why photodynamic therapy for skin cancer can cause pain

June 23, 2016
Severe paleness and photosensitivity are two symptoms of a rare group of hereditary diseases that affect haem, a substance in the blood. While these metabolic disorders - known as the porphyrias - are extremely rare, a similar ...

Topical treatment activates immune system to clear precancerous skin lesions

December 19, 2016
A combination of two FDA-approved drugs - a topical chemotherapy and an immune-system-activating compound - was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment ...

E-skin for manipulating virtual objects without touching them

January 22, 2018
A team of researchers from Germany and Austria has developed a type of e-skin that allows a wearer to control virtual objects without touching them. In their paper published on the open access site Science Advances, the group ...

Photodynamic therapy vs. cryotherapy for actinic keratoses

August 27, 2014
Photodynamic therapy (PDT, which uses topical agents and light to kill tissue) appears to better clear actinic keratoses (AKs, a common skin lesion caused by sun damage) at three months after treatment than cryotherapy (which ...

Recommended for you

Exercise-induced hormone irisin triggers bone remodeling in mice

December 13, 2018
Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Pain: Perception and motor impulses arise in brain independently of one another

December 13, 2018
Pain is a negative sensation that we want to get rid of as soon as possible. In order to protect our bodies, we react by withdrawing the hand from heat, for example. This action is usually understood as the consequence of ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers give new insight to muscular dystrophy patients

December 13, 2018
New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.